US pharmaceuticals giant Johnson & Johnson on Thursday announced it was buying Swiss medical firm Actelion for $30 billion (27.9 billion euros). Johnson & Johnson's CEO and chairman Alex Gorsky said in a statement that the acquisition of Actelion, a leader in medicines treating high blood pressure, offered "compelling value" to shareholders in both companies. |
GMT 12:07 2018 Tuesday ,23 January
Syria Kurds urge civilians to take up arms against Turk assaultGMT 12:03 2018 Tuesday ,23 January
Egypt military accuses presidential hopeful of crimes including forgeryGMT 11:41 2018 Tuesday ,23 January
UK regulator says Fox's Sky takeover 'not in public interest'GMT 11:38 2018 Tuesday ,23 January
South African jazz legend Hugh Masekela diesGMT 11:36 2018 Tuesday ,23 January
EU removes eight countries from tax haven listGMT 11:32 2018 Tuesday ,23 January
8.2 magnitude quake hits off Alaska: USGSGMT 11:28 2018 Tuesday ,23 January
Mattis calls for Turkish 'restraint' in SyriaGMT 03:43 2018 Tuesday ,23 January
Turkish soldier killed in Syria operation: armyMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor